​

Abeona Therapeutics (ABEO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

ABEO Stock Forecast

Abeona Therapeutics (ABEO) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $18.00, with a high of $20.00 and a low of $16.00. This represents a 188.00% increase from the last price of $6.25.

- $4 $8 $12 $16 $20 High: $20 Avg: $18 Low: $16 Last Closed Price: $6.25

ABEO Stock Rating

Abeona Therapeutics stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (62.50%), 3 Hold (37.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 3 5 Strong Sell Sell Hold Buy Strong Buy

ABEO Price Target Upside V Benchmarks

TypeNameUpside
StockAbeona Therapeutics188.00%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$20.00$20.00$18.00
Last Closing Price$6.25$6.25$6.25
Upside/Downside220.00%220.00%188.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2515---6
May, 2515---6
Apr, 2514---5
Mar, 2513---4
Feb, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 16, 2025Stephen WilleyStifel Nicolaus$20.00$6.10227.87%220.00%
Mar 05, 2025Oppenheimer$16.00$5.26204.18%156.00%
Nov 14, 2022Leerink Partners$6.00$4.1544.58%-4.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 15, 2025Alliance Global PartnersBuyBuyhold
Mar 05, 2025OppenheimerOutperforminitialise
Jul 03, 2024H.C. WainwrightBuyinitialise
May 16, 2024Cantor FitzgeraldOverweightOverweighthold
Nov 14, 2022SVB LeerinkMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

$-35 $-25 $-15 $-5 $5 $15 Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-23.84$-4.05$-2.53$-0.16----
Avg Forecast$-20.58$-3.92$-2.23$-1.65$-1.19$-0.39$1.50$4.09
High Forecast$-9.48$-2.80$-1.58$-1.57$-0.99$-0.08$12.86$6.31
Low Forecast$-32.90$-6.44$-3.44$-1.72$-1.48$-0.87$-9.86$2.89
Surprise %15.84%3.32%13.45%-90.30%----

Revenue Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.00M$1.41M$3.50M-----
Avg Forecast$12.37M$2.32M$3.63M$125.00K$19.78M$75.92M$217.60M$397.20M
High Forecast$18.06M$3.48M$5.14M$177.22K$26.88M$107.63M$308.50M$563.12M
Low Forecast$7.23M$1.81M$2.81M$96.89K$16.06M$58.85M$168.67M$307.88M
Surprise %-19.14%-39.13%-3.45%-----

Net Income Forecast

$-750M $-540M $-330M $-120M $90M $300M Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-88.35M$-31.81M$-54.19M$-63.73M----
Avg Forecast$-440.08M$-83.70M$-54.19M$-35.13M$-26.38M$-10.18M$8.95M$87.45M
High Forecast$-202.61M$-59.77M$-33.74M$-33.58M$-21.15M$-1.70M$274.89M$134.93M
Low Forecast$-703.51M$-137.68M$-73.57M$-36.69M$-31.62M$-18.66M$-210.75M$61.88M
Surprise %-79.92%-62.00%-81.42%----

ABEO Forecast FAQ

Is Abeona Therapeutics stock a buy?

Abeona Therapeutics stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Abeona Therapeutics is a favorable investment for most analysts.

What is Abeona Therapeutics's price target?

Abeona Therapeutics's price target, set by 8 Wall Street analysts, averages $18 over the next 12 months. The price target range spans from $16 at the low end to $20 at the high end, suggesting a potential 188.00% change from the previous closing price of $6.25.

How does Abeona Therapeutics stock forecast compare to its benchmarks?

Abeona Therapeutics's stock forecast shows a 188.00% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Abeona Therapeutics over the past three months?

  • June 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Abeona Therapeutics’s EPS forecast?

Abeona Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.19, marking a 643.75% increase from the reported $-0.16 in 2024. Estimates for the following years are $-0.39 in 2026, $1.5 in 2027, and $4.09 in 2028.

What is Abeona Therapeutics’s revenue forecast?

Abeona Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $19.78M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $75.92M, followed by $217.6M for 2027, and $397.2M for 2028.

What is Abeona Therapeutics’s net income forecast?

Abeona Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-26.383M, representing a -58.60% decrease from the reported $-63.734M in 2024. Projections indicate $-10.176M in 2026, $8.95M in 2027, and $87.45M in 2028.